Please login to the form below

Not currently logged in
Email:
Password:

New board member for Oxford Genome Sciences

Cancer-focused, UK-based genomics company Oxford Genome Sciences has asked Christopher Hibberd to join its board of directors.

Cancer-focused, UK-based genomics company Oxford Genome Sciences (OGeS) has asked Christopher Hibberd to join its board of directors.

The addition of Hibberd is due to his experience in business strategy and corporate development, specifically for the identification of strategic business opportunities in the areas of mergers, acquisitions, partnerships and alliances.

Hibberd is currently working as CEO of Astute Medical and prior to that worked for 10 years at Biosite, as senior vice-president of corporate development. OGeS partners with Biosite in the development of diagnostics for cancer based on OGeS' OGAP protein database.

Prior to Biosite, Hibberd was manager at Boston Consulting Group and was responsible for leading international consultants and client case teams in developing and implementing value-creating strategies for businesses in a variety of industry sectors.

Dr Christian Rohlff, CEO of OGeS, said: "I am very pleased to welcome Christopher to OGeS' Board of Directors. I am confident that his broad expertise will be valuable to support OGeS' corporate development at a time when we are transitioning from target discovery to building our own product pipeline of therapeutic antibodies."

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics